U.S., July 11 -- ClinicalTrials.gov registry received information related to the study (NCT07695727) titled 'Targeting GLUT1 to Control Autoimmunity in Type 1 Diabetes' on July 06.
Brief Summary: Type 1 Diabetes is an autoimmune disease in which immune cells contribute to the destruction of insulin-producing pancreatic beta cells. This study investigates whether targeting GLUT1, a glucose transporter involved in immune cell metabolism, may help modulate autoimmune responses associated with Type 1 Diabetes.
The study uses previously collected and biobanked peripheral blood mononuclear cell samples from individuals with Type 1 Diabetes. No additional visits, blood draws, or study-specific procedures will be performed on human participants....